Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
IGC Pharma, Inc. (IGC) had Return on Equity of -31.47% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$0.33M |
|
$-2.05M |
|
$0.27M |
|
$0.06M |
|
$2.26M |
|
$-1.93M |
|
$-0.12M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-1.93M |
|
$-1.87M |
|
109.49M |
|
109.49M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$1.31M |
|
$2.03M |
|
$8.42M |
|
$9.73M |
|
$3.10M |
|
$0.13M |
|
$0.13M |
|
$3.23M |
|
$6.50M |
|
$0.76M |
|
$6.50M |
|
114.35M |
|
| Cash Flow Statement Financials | |
$-3.99M |
|
$-0.62M |
|
$4.11M |
|
$0.90M |
|
$0.38M |
|
$-0.52M |
|
$2.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.42 |
|
-- |
|
-- |
|
0.02 |
|
0.13 |
|
18.60% |
|
-588.72% |
|
-588.72% |
|
-- |
|
-623.78% |
|
-623.78% |
|
$-4.00M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.42 |
|
4.82 |
|
18.66 |
|
|
Return on Equity |
-31.47% |
-268.86% |
|
-21.03% |
|
-30.86% |
|
$0.06 |
|
$-0.04 |
|
$-0.04 |
|